Market Signals Align with Georgia’s Life Sciences Roadmap
A new national outlook on the life sciences real estate market is reinforcing what many in Georgia’s ecosystem have been building toward: a more disciplined, workforce-driven, and manufacturing-focused future for the industry.
CBRE’s 2026 U.S. Life Sciences Market Outlook points to a sector in transition—moving away from rapid, speculative expansion toward a more measured phase defined by targeted growth, capital efficiency, and long-term sustainability.
For Georgia, these trends are not just informative—they are validating.
A Market Reset Creates Opportunity
After several years of rapid expansion in major coastal markets, the national lab space market is recalibrating. Construction has slowed significantly, and vacancy rates—while still elevated—are stabilizing.
This shift favors emerging markets like Georgia that have taken a more measured approach to growth.
Rather than contending with oversupply, Georgia is well-positioned to scale intentionally—aligning infrastructure, workforce, and industry demand in a way that supports long-term success.
Manufacturing and Scale-Up Are Driving Growth
One of the clearest signals from the CBRE report is the increasing role of large pharmaceutical and biomanufacturing investments in driving demand.
This aligns directly with Georgia’s recent momentum.
From major facility expansions to increased interest in onshoring and domestic production, the Southeast—and Georgia in particular—is becoming a destination for advanced manufacturing in the life sciences.
The Georgia Life Sciences Roadmap has consistently emphasized this opportunity:
- Strengthening biomanufacturing capacity
- Building workforce pipelines to support production scale
- Positioning Georgia as a hub for both innovation and commercialization
Workforce as the Differentiator
As capital becomes more selective and companies prioritize execution, talent—not space—is emerging as the defining constraint.
Georgia’s investments in workforce development, including partnerships with the Technical College System of Georgia and the Georgia Bioscience Training Center, position the state to meet this moment.
Through coordinated efforts across education, industry, and government, Georgia is building the kind of workforce infrastructure that enables companies to not only locate here—but to grow here.
A Converging Ecosystem
Another key trend highlighted in the report is the convergence of life sciences with adjacent sectors such as digital health, robotics, and advanced technologies. This is an area where Atlanta stands out.
With strengths in medtech, health IT, and data-driven healthcare solutions, the region offers a broader definition of “life sciences”—one that reflects where the industry is headed, not where it has been.
Looking Ahead
The national life sciences sector is entering a new phase—one that rewards strategic alignment, ecosystem coordination, and long-term investment.
Georgia is not starting from scratch in this environment. It has been building toward it. The Georgia Life Sciences Roadmap anticipated many of these shifts, prioritizing:
- Workforce development
- Manufacturing and scale-up capacity
- Industry-academic collaboration
- Capital and commercialization pathways
As national trends continue to evolve, Georgia’s focus on disciplined, intentional growth positions the state—and the broader Southeast—as a compelling partner in the next chapter of the life sciences industry.
Read report - CBRE Chapter 9, Life Sciences - U.S. Real Estate Market Outlook 2026
https://www.cbre.com/insights/books/us-real-estate-market-outlook-2026/life-sciences
